Status: current, Defined. Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3770829013 | Product containing only aspirin and glycine in oromucosal dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3770830015 | Aspirin and glycine only product in oromucosal dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Aspirin and glycine only product in oromucosal dose form | Is a | Aspirin- and glycine-containing product in oromucosal dose form | true | Inferred relationship | Some | ||
| Aspirin and glycine only product in oromucosal dose form | Has manufactured dose form | Oromucosal dose form | true | Inferred relationship | Some | ||
| Aspirin and glycine only product in oromucosal dose form | Count of base of active ingredient | 2 | false | Inferred relationship | Some | ||
| Aspirin and glycine only product in oromucosal dose form | Is a | Aspirin and glycine only product | true | Inferred relationship | Some | ||
| Aspirin and glycine only product in oromucosal dose form | Has active ingredient | Glycine | true | Inferred relationship | Some | 1 | |
| Aspirin and glycine only product in oromucosal dose form | Has active ingredient | Aspirin | true | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Aspirin 500 mg and glycine 133 mg orodispersible tablet | Is a | False | Aspirin and glycine only product in oromucosal dose form | Inferred relationship | Some |
Reference Sets
Description inactivation indicator reference set